Form 4 for INMB Inmune Bio, Inc.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-17 · accession 0001213900-23-021235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-20 | 2023-03-17 | INMB | Moss David J | CFO, Treas, Sec, 10% | P - Purchase | $6.43 | +2,500 | 1.25M | +0.2% | +$16.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-17 | P | A | 2,500 | $6.43 | 1,250,151 | D | — | — | (F1) The Reporting Person purchased 2,500 shares of the Issuer's Common Stock in an open market transaction on March 17, 2023. |